Auden Mckenzie’s focus in the development and commercialization of high value, technically demanding formulations as well as specialized and niche opportunities is complementary to and expands our generics business focus. The opportunity to combine this profitable and growing company with the Actavis UK business aligns with our strategy to establish a leading position in all of our markets, franchises and therapeutic categories.